Articles with public access mandates - Viraj MasterLearn more
Not available anywhere: 13
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label …
AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, ...
The Lancet 397 (10288), 1895-1904, 2021
Mandates: US National Institutes of Health
Age and grade trends in prostate cancer (1974–2003): a surveillance, epidemiology, and end results registry analysis
AB Jani, PAS Johnstone, SL Liauw, VA Master, OW Brawley
American journal of clinical oncology 31 (4), 375-378, 2008
Mandates: US National Institutes of Health
Stage IV prostate cancer: survival differences in clinical T4, nodal and metastatic disease
W Hsiao, KA Moses, M Goodman, AB Jani, PJ Rossi, VA Master
The Journal of urology 184 (2), 512-518, 2010
Mandates: US National Institutes of Health
Initial report of a randomized trial comparing conventional-vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer
A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, ...
International Journal of Radiation Oncology, Biology, Physics 108 (5), 1397, 2020
Mandates: US National Institutes of Health
Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer
RGW Quek, KC Ward, VA Master, CC Lin, KM Portier, KS Virgo, ...
Journal of the National Comprehensive Cancer Network 13 (3), 303-309, 2015
Mandates: US National Institutes of Health
Association of reimbursement policy and urologists׳ characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer
RGW Quek, VA Master, KM Portier, KC Ward, CC Lin, KS Virgo, ...
Urologic Oncology: Seminars and Original Investigations 32 (6), 748-760, 2014
Mandates: US National Institutes of Health
Rise in node-positive prostate cancer incidence in context of evolving use and extent of pelvic lymphadenectomy
MA Taylor, M Alemozaffar, VA Master, MG Sanda, CP Filson
Clinical Genitourinary Cancer 17 (3), e494-e504, 2019
Mandates: US National Institutes of Health
PERSONALIZED DECISION SUPPORT FOR LOCALIZED PROSTATE CANCER: RESULTS OF A MULTI-SITE RANDOMIZED TRIAL: PD06-03
D Berry, F Hong, T Blonquist, B Halpenny, M Sanda, V Master, C Filson, ...
Journal of Urology 197 (4), e122, 2017
Mandates: US National Institutes of Health
High expression of major histocompatibility complex class I in clear cell renal cell carcinoma is associated with improved prognosis
SA Holzman, CM de la Calle, HT Kissick, AO Osunkoya, BP Pollack, ...
Urologia internationalis 95 (1), 72-78, 2015
Mandates: US Department of Veterans Affairs
MP36-01
R Nabavizadeh, G Lee, D Patil, C Moreno, V Master
THE JOURNAL OF UROLOGY 203 (4S), 2020
Mandates: National Natural Science Foundation of China
LIQUID BIOPSY FOR RENAL CELL CARCINOMA: PNFBA-12
U Al-Qassab, AC Lorentz, D Laganosky, K Ogan, V Master, J Pattaras, ...
Journal of Urology 197 (4), e913-e914, 2017
Mandates: US Department of Veterans Affairs
Advanced Molecular Imaging with anti-3-[18F] FACBC PET-CT to Improve the Selection and Outcomes of Prostate Cancer Patients Receiving Post-prostatectomy Radiotherapy
DM Schuster, PJ Rossi, K Godette, R Halkar, M Goodman, Z Chen, P Nieh, ...
Mandates: US National Institutes of Health
EVALUATION OF TUMOR PD-1 EXPRESSION AS A PROGNOSTIC BIOMARKER IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA: MP92-02
K Kim, R Sekar, M DiMarco, D Patil, A Osunkoya, G Sica, H Kissick, ...
Journal of Urology 195 (4), e1161-e1162, 2016
Mandates: US National Institutes of Health
Available somewhere: 105
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, ...
Nature 576 (7787), 465-470, 2019
Mandates: US National Institutes of Health
Active surveillance for the management of prostate cancer in a contemporary cohort
MA Dall'Era, BR Konety, JE Cowan, K Shinohara, F Stauf, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
Mandates: US National Institutes of Health
Hyperspectral imaging and quantitative analysis for prostate cancer detection
H Akbari, LV Halig, DM Schuster, A Osunkoya, V Master, PT Nieh, ...
Journal of biomedical optics 17 (7), 076005-076005, 2012
Mandates: US National Institutes of Health
Anti-3-[18F]FACBC Positron Emission Tomography-Computerized Tomography and 111In-Capromab Pendetide Single Photon Emission Computerized …
DM Schuster, PT Nieh, AB Jani, R Amzat, FDB Bowman, RK Halkar, ...
The Journal of urology 191 (5), 1446-1453, 2014
Mandates: US National Institutes of Health
Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In–Capromab Pendetide SPECT/CT
DM Schuster, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, PJ Rossi, ...
Radiology 259 (3), 852-861, 2011
Mandates: US National Institutes of Health
Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT
OA Odewole, FI Tade, PT Nieh, B Savir-Baruch, AB Jani, VA Master, ...
European journal of nuclear medicine and molecular imaging 43, 1773-1783, 2016
Mandates: US National Institutes of Health
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
N Prokhnevska, MA Cardenas, RM Valanparambil, E Sobierajska, ...
Immunity 56 (1), 107-124. e5, 2023
Mandates: US Department of Defense, US National Institutes of Health
Publication and funding information is determined automatically by a computer program